The Integrin v 3-5 Ligand MFG-E8 Is a P63/P73 Target Gene in Triple-Negative Breast Cancers but Exhibits Suppressive Functions in ER+ and erbB2+ Breast Cancers

Cancer Research - United States
doi 10.1158/0008-5472.can-10-1471
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Molecular Stratification of Triple-Negative Breast Cancers

Oncologist
Cancer ResearchMedicineOncology
2010English

BRCA1/2-negative Hereditary Triple-Negative Breast Cancers Exhibit BRCAness

International Journal of Cancer
Cancer ResearchOncology
2017English

Transgelin: A Potentially Useful Diagnostic Marker Differentially Expressed in Triple-Negative and Non–triple-Negative Breast Cancers

Human Pathology
Forensic MedicinePathology
2015English

BRCA1-IRIS Inactivation Overcomes Paclitaxel Resistance in Triple Negative Breast Cancers

Breast Cancer Research
Cancer ResearchOncology
2015English

Profiling Molecular Regulators of Recurrence in Chemorefractory Triple-Negative Breast Cancers

Breast Cancer Research
Cancer ResearchOncology
2019English

Genetic Variations in Triple-Negative Breast Cancers Undergoing Neo-Adjuvant Chemotherapy

2019English

Overview on Epigenetic Re-Programming: A Potential Therapeutic Intervention in Triple Negative Breast Cancers

Asian Pacific Journal of Cancer Prevention
2018English

Brachyury, a Vaccine Target, Is Overexpressed in Triple-Negative Breast Cancer

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2016English

Distinct P53 Gene Signatures Are Needed to Predict Prognosis and Response to Chemotherapy in ER-Positive and ER-Negative Breast Cancers

Clinical Cancer Research
Cancer ResearchOncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy